Context Therapeutics Inc. (CNTX) is a publicly traded company in the Unknown sector. Across all available filings, 5 corporate insiders have executed 24 transactions totaling $295.3K, demonstrating a bullish sentiment with $295.3K in net insider flow. The most recent transaction on Feb 21, 2023 involved a purchase of 5,823 shares valued at $4.9K.
No significant insider buying has been recorded for CNTX in the recent period.
No significant insider selling has been recorded for CNTX in the recent period.
Based on recent SEC filings, insider sentiment for CNTX is bullish with an Insider Alignment Score of 100/100 and a net flow of $295.3K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Context Therapeutics Inc. (CNTX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 5 insiders are actively trading CNTX stock, having executed 24 transactions in the past 90 days. The most active insider is Martin A. Lehr (Executive), who has made 17 transactions totaling $962.5K.
Get notified when executives and directors at CNTX file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Feb 21, 2023 | A. Lehr Martin | Executive | Purchase | 5,823 | $0.84 | $4.9K | |
| Feb 13, 2023 | A. Lehr Martin | Executive | Purchase | 5,606 | $0.87 | $4.9K | |
| Feb 6, 2023 | A. Lehr Martin | Executive | Purchase | 5,040 | $0.97 | $4.9K | |
| Jan 30, 2023 | A. Lehr Martin | Executive | Purchase | 7,027 | $0.70 | $4.9K | |
| Jan 23, 2023 | A. Lehr Martin | Executive | Purchase | 6,839 | $0.72 | $4.9K | |
| Jan 17, 2023 | A. Lehr Martin | Executive | Purchase | 6,783 | $0.74 | $5.0K | |
| Dec 16, 2022 | A. Lehr Martin | Executive | Purchase | 20,000 | $0.74 | $14.8K | |
| Dec 16, 2022 | Lynn Minai-azary Jennifer | Executive | Purchase | 25,000 | $0.74 | $18.5K | |
| Dec 9, 2022 | C. Levit Alex | Executive | Purchase | 6,000 | $0.85 | $5.1K | |
| Aug 19, 2022 | A. Lehr Martin | Executive | Purchase | 13,000 | $1.85 | $24.1K | |
| Aug 17, 2022 | Lynn Minai-azary Jennifer | Executive | Purchase | 15,000 | $1.80 | $27.0K | |
| Aug 16, 2022 | Sahmoud Tarek | Executive | Purchase | 10,000 | $1.95 | $19.5K | |
| Dec 16, 2021 | A. Lehr Martin | Executive | Purchase | 13,000 | $3.22 | $41.9K | |
| Oct 22, 2021 | G. Dick Evan | Executive | Conversion | 26,587 | $N/A | $0 | |
| Oct 22, 2021 | A. Lehr Martin | Executive | Conversion | 586,476 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Other(O) | 2 | $752.3K | 71.8% |
Purchase(P) | 16 | $295.3K | 28.2% |
Conversion(C) | 6 | $0 | 0.0% |
Insiders at Context Therapeutics Inc. are accumulating shares at an accelerated pace. With 5 insiders making 24 transactions totaling $295.3K in purchases versus $0 in sales, the net buying activity of $295.3K signals strong executive confidence. Martin A. Lehr (Executive) leads the buying activity with $962.5K in transactions across all time.